WallStSmart

Coca-Cola Femsa SAB de CV ADR (KOF)vsSRx Health Solutions Inc. (SRXH)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola Femsa SAB de CV ADR generates 2317554% more annual revenue ($296.20B vs $12.78M). KOF leads profitability with a 8.1% profit margin vs 0.0%. SRXH trades at a lower P/E of 0.0x. KOF earns a higher WallStSmart Score of 56/100 (C).

KOF

Buy

56

out of 100

Grade: C

Growth: 6.0Profit: 6.5Value: 4.7Quality: 5.5
Piotroski: 3/9Altman Z: 2.47

SRXH

Avoid

34

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 5.3
Piotroski: 2/9Altman Z: -5.50
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KOFUndervalued (+59.6%)

Margin of Safety

+59.6%

Fair Value

$279.04

Current Price

$115.56

$163.48 discount

UndervaluedFair: $279.04Overvalued

Intrinsic value data unavailable for SRXH.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KOF1 strengths · Avg: 8.0/10
Free Cash FlowQuality
$8.86B8/10

Generating 8.9B in free cash flow

SRXH2 strengths · Avg: 10.0/10
P/E RatioValuation
0.0x10/10

Attractively priced relative to earnings

Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Areas to Watch

KOF4 concerns · Avg: 2.8/10
Revenue GrowthGrowth
4.7%4/10

4.7% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
18.102/10

Expensive relative to growth rate

P/E RatioValuation
149.5x2/10

Premium valuation, high expectations priced in

SRXH4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$24.02M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : KOF

The strongest argument for KOF centers on Free Cash Flow.

Bull Case : SRXH

The strongest argument for SRXH centers on P/E Ratio, Price/Book.

Bear Case : KOF

The primary concerns for KOF are Revenue Growth, Piotroski F-Score, PEG Ratio. A P/E of 149.5x leaves little room for execution misses.

Bear Case : SRXH

The primary concerns for SRXH are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

KOF is growing revenue faster at 4.7% — sustainability is the question.

KOF generates stronger free cash flow (8.9B), providing more financial flexibility.

Monitor BEVERAGES - NON-ALCOHOLIC industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KOF scores higher overall (56/100 vs 34/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola Femsa SAB de CV ADR

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola FEMSA, SAB de CV, a franchise bottler, produces, markets, sells and distributes Coca-Cola brand beverages. The company is headquartered in Mexico City, Mexico.

Visit Website →

SRx Health Solutions Inc.

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

SRx Health Solutions Inc. provides healthcare and medical treatment services.

Visit Website →

Want to dig deeper into these stocks?